Clinical Analysis and Optimization of Postremission Therapy for Acute Myeloid Leukemia Patients with Minimal Residual Disease as Determined by Flow Cytometry.

BACKGROUND: Although several prognostic indicators of de novo acute myeloid leukemia (AML) patients have been identified, the clinical significance of minimal residual disease (MRD) needs to be evaluated further in Japanese adult patients. METHODS: Using three color flow cytometry, we identified leu...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Daichi, Maruoka, Hayato, Takahashi, Takayuki
Formato: Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2010
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033143/
https://www.ncbi.nlm.nih.gov/pubmed/21415971
http://dx.doi.org/10.4084/MJHID.2010.020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033143/
https://www.ncbi.nlm.nih.gov/pubmed/21415971
http://dx.doi.org/10.4084/MJHID.2010.020

Ejemplares similares